Bisoprolol Export Market Intelligence: India's 245 Suppliers Shipping to 121 Countries — TransData Nexus 2026

Q: Who are the top bisoprolol exporters from India?

The top bisoprolol exporters from India are: 1. UNICHEM LABORATORIES LIMITED — $28.9M (34.2% market share); 2. FREDUN PHARMACEUTICALS LTD — $16.4M (19.4% market share); 3. IPCA LABORATORIES LIMITED — $9.1M (10.8% market share); 4. AUROBINDO PHARMA LTD — $4.8M (5.7% market share); 5. MEDREICH LIMITED — $4.0M (4.8% market share). Together they account for 74.9% of India's total bisoprolol export value.

Q: What is the total export value of bisoprolol from India?

The total export value of bisoprolol from India is $84.5M USD, recorded across 4,276 shipment transactions from 245 active exporters to 121 destination countries. The average shipment value is $19.8K.

Q: Which countries import bisoprolol from India?

India exports bisoprolol to 121 countries worldwide. The top importing countries are: UNITED STATES (34.4% share, $29.1M), CYPRUS (19.4% share, $16.4M), UNITED KINGDOM (11.4% share, $9.6M), CROATIA (5.0% share, $4.2M), BRAZIL (4.5% share, $3.8M). These five markets account for 74.6% of total export value.

Q: What is the HS code for bisoprolol exports from India?

The primary HS code for bisoprolol exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of bisoprolol exports from India?

The average unit price for bisoprolol exports from India is $305.52 USD per unit, with prices ranging from $0.00 to $24461.31 depending on formulation, packaging, and order volume. The total market is valued at $84.5M across 4,276 shipments.

Q: Which ports handle bisoprolol exports from India?

The primary ports for bisoprolol exports from India are NHAVA SHEVA SEA (INNSA1) (10.8% of shipments), SAHAR AIR (10.0% of shipments), JNPT/ NHAVA SHEVA SEA (9.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.6% of shipments), JNPT (5.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of bisoprolol?

India is one of the world's leading exporters of bisoprolol due to its large base of 245 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports bisoprolol to 121 countries, demonstrating 62% global market coverage.

Q: What certifications do Indian bisoprolol exporters need?

Indian bisoprolol exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import bisoprolol from India?

There are 585 registered buyers importing bisoprolol from India, spread across 121 countries. The repeat buyer rate is 68.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top bisoprolol supplier from India?

UNICHEM LABORATORIES LIMITED is the leading bisoprolol exporter from India with a market share of 34.2% and total export value of $28.9M across 422 shipments. The top 5 suppliers together control 74.9% of total export value.

Suresh Sormare

Bisoprolol

India Pharmaceutical Trade Intelligence

$84.5M245 Suppliers121 CountriesHS 30049079

ExportsIndia → UNITED STATES34.4%India → CYPRUS19.4%

ImportsGERMANY → India$385.1K FRANCE → India$84.6K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Bisoprolol Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Bisoprolol to the World

Between 2022 and 2026, India exported $84.5M worth of bisoprolol across 4,276 verified shipments to 121 countries — covering 62% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (34.4%). UNICHEM LABORATORIES LIMITED leads with a 34.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Bisoprolol export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Bisoprolol export data snapshot — $84.5M · 245 exporters · 121 countriesTransData Nexus · Indian Customs Data

Top Bisoprolol Exporters from India

245 active exporters · Ranked by export value

View all 245 →

Top Bisoprolol Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	UNICHEM LABORATORIES LIMITED	$28.9M	422	12	34.2%
2	FREDUN PHARMACEUTICALS LTD

Top Countries Importing Bisoprolol from India

121 destination markets · Ranked by import value

All 121 countries →

Top Countries Importing Bisoprolol from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$29.1M	34.4%
2	CYPRUS	$16.4M	19.4%
3	UNITED KINGDOM	$9.6M	11.4%
4	CROATIA	$4.2M	5.0%
5	BRAZIL	$3.8M	4.5%
6	SOUTH AFRICA	$1.6M	1.9%
7	ISRAEL	$1.4M	1.7%
8	CHILE	$1.4M	1.7%
9	MALTA	$1.4M	1.7%
10	CANADA	$1.1M	1.3%

UNITED STATES is India's largest bisoprolol export destination, absorbing 34.4% of total exports worth $29.1M. The top 5 importing countries — UNITED STATES, CYPRUS, UNITED KINGDOM, CROATIA, BRAZIL — together account for 74.6% of India's total bisoprolol export value. The remaining 116 destination countries collectively receive the other 25.4%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Bisoprolol to India?

19 origin countries · Total import value: $539.9K

India imports bisoprolol from 19 countries with a combined import value of $539.9K. The largest supplier is GERMANY ($385.1K, 72 shipments), followed by FRANCE and LATVIA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Bisoprolol to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$385.1K	72	71.3%
2	FRANCE	$84.6K	7	15.7%
3	LATVIA	$26.9K	6	5.0%
4	UNITED STATES	$25.4K	239	4.7%
5	UNITED KINGDOM	$6.0K	12	1.1%
6	MALAYSIA	$3.2K	4	0.6%
7	CANADA	$3.0K	60	0.5%
8	IRELAND	$1.7K	16	0.3%
9	NETHERLANDS	$1.1K	1	0.2%
10	HUNGARY	$928	40	0.2%

Showing top 10 of 19 origin countries

GERMANY is the largest supplier of bisoprolol to India, accounting for 71.3% of total import value. The top 5 origin countries — GERMANY, FRANCE, LATVIA, UNITED STATES, UNITED KINGDOM — together supply 97.8% of India's bisoprolol imports. Click any country to see detailed supplier and buyer data for that import corridor.

Bisoprolol — Export Intelligence Video

Visual overview of India's bisoprolol import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's bisoprolol pharmaceutical import and export market — $84.5M in total trade, 245 verified manufacturers, and 121 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Bisoprolol

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, bisoprolol is approved under the brand name Zebeta, with the original New Drug Application (NDA 19-982) approved on July 31, 1992. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for bisoprolol, indicating a competitive generic market. As of March 2026, there are no active FDA import alerts specifically targeting bisoprolol products from India, suggesting compliance with U.S. regulatory standards. The substantial number of Indian exporters (245) underscores the robust participation of Indian manufacturers in the U.S. bisoprolol market.

2EU & UK Regulatory Framework

In the European Union, bisoprolol is subject to marketing authorization by the European Medicines Agency (EMA). On February 15, 2023, the EMA recommended the authorization of Rambis, a combination of ramipril and bisoprolol, indicating ongoing regulatory evaluations and approvals for bisoprolol-containing products. The United Kingdom, through the Medicines and Healthcare products Regulatory Agency (MHRA), aligns with EMA standards, requiring compliance with EU Good Manufacturing Practice (GMP) guidelines for bisoprolol products.

3WHO Essential Medicines & Global Standards

Bisoprolol is included in the World Health Organization's (WHO) Model List of Essential Medicines, reflecting its importance in global health. While specific editions of the list should be consulted for confirmation, its inclusion underscores the drug's recognized efficacy and safety. Bisoprolol formulations are standardized across major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and therapeutic equivalence worldwide.

4India Regulatory Classification

In India, bisoprolol is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, bisoprolol is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for pharmaceutical products, ensuring compliance with international standards and regulations.

5Patent & Exclusivity Status

The primary patents for bisoprolol have expired, facilitating the entry of generic versions into the market. This has led to increased competition among manufacturers, including Indian exporters, contributing to the drug's widespread availability and affordability globally.

6Recent Industry Developments

In December 2022, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended the authorization of Rambis, a combination of ramipril and bisoprolol, highlighting ongoing developments in combination therapies involving bisoprolol. In October 2025, the EMA issued a variation to the marketing authorization for bisoprolol/hydrochlorothiazide products, emphasizing the need for updated product information regarding the risk of hypoglycemia when used concomitantly with sulfonylureas. These regulatory actions reflect the dynamic nature of bisoprolol's market and the importance of continuous monitoring and compliance with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Bisoprolol

Retail & reference prices across 9 markets vs. India FOB export price of $305.52/unit

Global Price Benchmark for Bisoprolol across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA Orange Book, Bisoprolol is an approved generic medication, contributing to its competitive pricing.
United Kingdom	$0.28	GBP	The NHS Drug Tariff, as of March 2026, lists Bisoprolol 5 mg tablets at £0.20 per unit, reflecting the UK's centralized procurement system.
Germany	$0.27	EUR	The German Federal Joint Committee (G-BA) includes Bisoprolol in its reference pricing system, ensuring affordability.
Australia	$0.25

Supply Chain Risk Assessment — Bisoprolol

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 70% of India's API imports originate from China, underscoring a significant dependency. This reliance exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or production halts in China. For instance, environmental regulations in China have previously led to the shutdown of chemical manufacturing units, causing supply shortages and price volatility for Indian pharmaceutical companies.

To mitigate this dependency, the Indian government launched the Production Linked Incentive (PLI) scheme for bulk drugs in 2020, aiming to bolster domestic production of critical APIs and KSMs. By August 2025, the scheme had approved 48 projects across 33 APIs/KSMs, resulting in cumulative sales of INR 19.62 billion (approximately $218.3 million USD) and import substitution worth INR 14.83 billion (around $165 million USD). Despite these efforts, the transition to self-reliance is gradual, and the industry remains vulnerable to external supply chain disruptions.

2Supplier Concentration & Single-Source Risk

The bisoprolol export market from India is notably concentrated among a few suppliers. The top five exporters—Unichem Laboratories Limited, Fredun Pharmaceuticals Ltd, IPCA Laboratories Limited, Aurobindo Pharma Ltd, and Medreich Limited—collectively account for 74.9% of the total export value. Unichem Laboratories Limited alone contributes 34.2% of the exports, indicating a high level of supplier concentration. Such dependency on a limited number of suppliers increases the risk of supply chain disruptions due to operational issues, regulatory challenges, or financial instability within these companies.

Access Complete Bisoprolol Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,276 transactions across 121 markets.

Request Demo View Pricing

Frequently Asked Questions — Bisoprolol Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top bisoprolol exporters from India?

The leading bisoprolol exporters from India are UNICHEM LABORATORIES LIMITED, FREDUN PHARMACEUTICALS LTD, IPCA LABORATORIES LIMITED, and 12 others. UNICHEM LABORATORIES LIMITED leads with 34.2% market share ($28.9M). The top 5 suppliers together control 74.9% of total export value.

What is the total export value of bisoprolol from India?

The total export value of bisoprolol from India is $84.5M, recorded across 4,276 shipments from 245 active exporters to 121 countries. The average shipment value is $19.8K.

Which countries import bisoprolol from India?

India exports bisoprolol to 121 countries. The top importing countries are UNITED STATES (34.4%), CYPRUS (19.4%), UNITED KINGDOM (11.4%), CROATIA (5.0%), BRAZIL (4.5%), which together account for 74.6% of total export value.

What is the HS code for bisoprolol exports from India?

The primary HS code for bisoprolol exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Bisoprolol

Bisoprolol

Top Bisoprolol Exporters from India

Top Countries Importing Bisoprolol from India

Who Supplies Bisoprolol to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Bisoprolol — Export Intelligence Video

Regulatory Landscape — Bisoprolol

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Bisoprolol

Supply Chain Risk Assessment — Bisoprolol

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Bisoprolol Trade Intelligence

Frequently Asked Questions — Bisoprolol Exports from India

Who are the top bisoprolol exporters from India?

What is the total export value of bisoprolol from India?

Which countries import bisoprolol from India?

What is the HS code for bisoprolol exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of bisoprolol exports from India?

Which ports handle bisoprolol exports from India?

Why is India a leading exporter of bisoprolol?

What certifications do Indian bisoprolol exporters need?

How many buyers import bisoprolol from India?

What is the market share of the top bisoprolol exporter from India?

Analysis Methodology